Dr. Iris Jousten SRL

Dr. Iris Jousten reported total assets of 54,831 € at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Jun 2026).

Company number (CBE) 0685.559.277 · VAT BE0685559277
1330 Rixensart
active in Medical specialists activities (NACE 86220)
operating since 01 Dec 2017 (≈ 9 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Dr. Iris Jousten shows with a free account.

See the score
Profile
SRL since 2017
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result24,239 €
Equity14,290 €
Cash45,899 €
EBITDA35,466 €
Total assets54,831 €
The line marks its sector median: 65.0% (4535 companies).

Change 2022 → 2025: Equity -23 % Total assets +78 %

Accounts of the company itself (not consolidated).

The full file covers 8 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Dr. Iris Jousten's annual accounts

20252024202320222021
Net result24,239 €
Equity14,290 €
Cash45,899 €
EBITDA35,466 €
Total assets54,831 €

Filed annual accounts

  • Year ended 31 Dec 2025filed on 29 Jun 2026
  • Year ended 31 Dec 2024filed on 10 Jul 2025
  • Year ended 31 Dec 2023filed on 28 Jun 2024
  • Year ended 31 Dec 2022filed on 13 Jun 2023
  • Year ended 31 Dec 2021filed on 14 Jun 2022

Dr. Iris Jousten's financial analysis

Management and control of Dr. Iris Jousten

1 active director(s) in the register.

Dr. Iris Jousten's shareholders and holdings →

Dr. Iris Jousten's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0685.559.277
VAT number
BE0685559277
Peppol
Not found on Peppol as of 10 Nov 2026 · Check
Legal form
SRL
Incorporated
01 Dec 2017
Registered office
1330 Rixensart
Latest accounts
2025 · filed on 29 Jun 2026
Activity
Medical specialists activities (NACE 86220)

Dr. Iris Jousten (SRL) has been based in Rixensart since 2017, active in: medical specialists activities. For 2025, it reports a net profit of 24,239 € and equity of 14,290 €; its revenue is not published. Its solvency stands at 26.1%, below the median of its sector (65.0%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Dr. Iris Jousten

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Dr. Iris Jousten

What is the revenue of Dr. Iris Jousten?

Dr. Iris Jousten files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Dr. Iris Jousten?

In Belgium, the VAT number is the company number prefixed with BE: BE0685559277 for Dr. Iris Jousten, if the company is VAT-registered. Its company number (CBE) is 0685.559.277.

Where is the registered office of Dr. Iris Jousten?

According to the CBE register, the registered office of Dr. Iris Jousten is in 1330 Rixensart.

What is the equity of Dr. Iris Jousten?

At the close of the 2025 financial year, the equity of Dr. Iris Jousten amounts to 14,290 €, a solvency of 26.1% of total assets.

Who manages Dr. Iris Jousten?

The register lists 1 active mandates at Dr. Iris Jousten. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Dr. Iris Jousten

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 01 Aug 2026

No credit card, no commitment.

What each plan unlocks →